SCHEMBL799502

SCHEMBL799502

CC(=O)SCCCc1ccc(-c2ccc(-c3cccs3)s2)s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.52
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
LMNA P02545 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
GAA P10253 2/20 0.48
GLA P06280 1/20 0.48
MAPT P10636 1/20 0.48
LTA4H P09960 1/20 0.47
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
NFKB1 P19838 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL799956 0.82 DPP4 (0.55) DPP4ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL799558 0.79 HPGD (0.36) DPP4ALDH1A1LMNAHPGDHDAC1
SCHEMBL799957 0.77 HPGD (0.36) ALDH1A1LMNAHPGDHDAC1
SCHEMBL13467158 0.76 DPP4 (0.55) DPP4ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL8575618 0.75 DPP4 (0.67) DPP4ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL26625918 0.75 LTA4H (0.73) DPP4ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL14284941 0.75 DPP4 (0.57) DPP4ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL2769963 0.75 DPP4 (0.57) DPP4ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL2028518 0.75 DPP4 (0.57) DPP4ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL2864192 0.75 TAAR1 (0.49) ALDH1A1L3MBTL1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8663451-B2 Linker, impedance biochip, and method of quantitatively detecting target analyte in fluid sample using the biochip NATIONAL TAIWAN UNIVERSITY (TW) 2014-03-04 US disclosed
US-20120067742-A1 LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP NATIONAL TAIWAN UNIVERSITY (TW) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120067742-A1 LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP EPCAM, CA13, CD44 DPP4 4118/4885ALDH1A1 1831/4885KDM4E 3599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.